High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer
نویسندگان
چکیده
منابع مشابه
High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer.
A randomised study comparing cisplatin 120 mg intravenously with cyclophosphamide 2 g intravenously, each drug being given every month for six months followed by a low dose regimen for a further six months in responding patients, was carried out in 86 patients with advanced epithelial ovarian carcinoma (FIGO stages III and IV). Patients given cisplatin were found to have a longer median surviva...
متن کاملCost effectiveness of paclitaxel/cisplatin compared with cyclophosphamide/cisplatin in the treatment of advanced ovarian cancer in Belgium.
OBJECTIVE To assess the economic impact of two polychemotherapy regimens for patients with advanced ovarian cancer from the perspective of the Belgian health insurance and financing system. DESIGN An economic evaluation was integrated in an intergroup randomised controlled trial (EORTC 55931) in which patients were randomised to receive the new treatment of paclitaxel and cisplatin or the sta...
متن کاملFailure to Demonstrate the Role of High Risk Human Papilloma Virus in Epithelial Ovarian Cancer
Background and Aims: Ovarian cancer is one of most common causes of cancer related women's mortalities. Human papilloma virus is a known factor concerning cervical cancer but its role in causing ovarian cancer is not yet verified. A few studies also identified HPV DNA in ovarian carcinoma tissues. However, some studies did not detect HPV DNA in ovarian carcinoma tissues. In this articl...
متن کاملRapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer.
PURPOSE The purpose of this study was to evaluate the efficacy of rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for previously untreated patients with advanced head and neck cancer. METHODS Forty-three patients for whom surgery was contraindicated or who rejected radical surgery were given superselective intra-arterial infusions of cisplatin (100-120 mg/m2/we...
متن کاملA phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.
these credentials it is quite remarkable that this agent has never had anything approaching an adequate Phase II trial in gastrointestinal cancer. Among 5 different small studies reviewed by Livingston and Carter (1) there were 47 colorectal patients treated with Cyclophosphamide by vari ous schedules, and the rates of objective response varied from 0 to 25%. The purpose of our investigation wa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1985
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.290.6478.1351